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Globally the burden of intrauterine deaths (IUD), 
Stillbirths (SB), Neonatal deaths (NND) is still high 
though the occurrence of SB has fallen from around 35 
for every 1000 live births in 1980 to around 15/1000 
live births in 2015.  McClure et al [1] reported that 
around 98 percent of SB occurred in low and middle 
income countries where SB have been substantially 
higher, 21 for every 1000 live births compared to 12 
deaths/1000 live births in high income countries. Still 
the SB numbers have been high even in high income 
countries if one looks at other vital statistics. Overall 
SBRs have been strongly linked to, maternal age, <25 
years and > 35 years, race, socioeconomic deprivation, 
rural residence, female illiteracy, chewing tobacco, illicit 
drugs, uterine abnormalities, less than four times 
antenatal care which are not always possible to 
manage by health providers. However, health providers 
can do a lot for other things. Quite a lot is known since 
decades about pre-existing medical disorders like 
anaemia, sickle cell anaemia, hyperthyroidism, 
hypothyroidism, diabetes, renal disorders, Systemic 
Lupus Erythomatosis and so on which lead to IUD. It 
could be any other non - obstetric complications. 
Including hepatitis intrahepatic cholestasis during 
pregnancy. Lethal malformations, placental 
abnormalities and foetal growth restriction (FGR) are 
known leading causes of SB. Further gestational 
diabetes, pregnancy induced hypertension, 
preeclampsia, hydramnios and oligohydromnios, 
placental abnormalities in structure, vascular 
malformations, placental abruption, fetomaternal 
hemorrhage, haemorrhage of unknown origin, 
preterm/term pre labour rupture of membranes, 
vasaprevia, chorioamnionitis, or umbilical cord  
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accidents such as knot in cord or cord prolapse or vasa 
previa are all known to be fatal. Maternal infections are 
one of the important causes of SB as well as NND, 
birth defects, low birth weight (LBW) or preterm births. 
Common ascending bacterial infection (with or without 
membrane rupture) may be caused by E.coli, 
klebsiella, Group B steptcoccus, Enteroccocus, 
Mycoplasm ureaplasma, Haemophilus and Chlamydia.  
It could be genetic abnormalities, multiple gestation, 
congenital abnomalies, fetal infection, post maturity. , 
hydrops fetalis, arrhythmia, platel et al. loimmunization. 
Various congenital anomalies have been identified to 
be associated with younger maternal age, the risk of 
age mainly attributed to omphalocele /gatrochiasis and 
for musculoskeletal /intugemental anomalies. Most 
common genetic etiology for SB is due to karyotype 
abnormalities but many SB foetuses with normal 
karyotype also have genetic abnormalities. In a nested 
case-control study within the intergenerational cohort 
held in the Aberdeen Maternity and Neonatal Databank 
(AMND) in Aberdeen, United Kingdom in which all 
mothers who had at least one daughter between 1949 
and 2000 were included there was no evidence of an 
inherited predisposition to SB transmitted from mother 
to daughter [2]. Quite a lot is still not known to the world 
about sudden IUD. Many IUDs remain unexplained 
despite autopsy; the rates vary from around 30 to 60% 
depending on interpretation of significance of features 
[3]. In Japan, it was reported that IUD due to fetal 
abnormalities reduced, but IUD associated with 
umbilical cord abnormalities increased relatively [4]. 
Migrant women’s overall increased risk of adverse 
pregnancy outcome SB, NND is well known. Autopsy in 
the prenatal, perinatal and paediatric setting helps to 
establish the cause of death. But to get consent for 
autopsy is also not easy. In a study just over 50 % of 
bereaved parents said they will consent to a standard 
autopsy (either minimally invasive autopsy (MIA), non – 
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invasive autopsy (NIA) or both). The qualitative study 
by James [5] suggested that parents value MIA 
because of lack of incision. Less invasive methods of 
autopsy may be more acceptable to bereaved parents 
than a standard autopsy. A lot of action oriented 
research is needed. 
Worldwide reduction of ENND has significantly 
lagged behind other Millennium Developmental Goal 
achievements. Sudden unexplained ENND continues 
to be a dilemma. In a study early NND contributed to 
73% postnatal deaths [6].  
 Most common reported causes of NNDs are 
perinatal asphyxia, severe neonatal infections, 
complications of preterm births like respiratory distress 
syndrome, Intraventricular hemorrhage or necrotizing 
enterocolitis. Although in preterm babies survival rates 
have improved in high income countries many preterm 
newborns still die because of lack of adequate care in 
many low and middle income countries. Early preterm 
birth (EPB, less than 34 weeks) is the main cause of 
neonatal death and severe disability [7]. Most women 
who experience EPB are at low risk. The severe 
consequences of EPB, high cost and need for clinical 
expertise in existing strategies of prevention are 
obvious reasons for attempts at prevention. 
Implementation of omega 3 long chain polyunsaturated 
fatty acids (omega -3 LCPUFA) supplements in 
pregnancy is now a feasible and cost-effective public 
health strategy [8, 9]. The Cochrane review concluded 
the minimum effective dose is 500 mg of DHA each 
day from week 12 of pregnancy [9]. Omega -3 LCPUFA 
is not a drug nor is it covered by a patent. It can be 
manufactured easily in accredited health food 
supplement factories. A lot needs to be researched 
about many development issues in those who survive 
after being born very very preterm. In a multicountry 
study of the 38 countries with high quality data preterm 
births increased since 2000 in 26 countries and 
decreased in 12 countries [10]. Preterm birth rates 
were 9.8 % (8.3 to 10.9%) in 2000, and 10.6 % (9 to 12 
%) in 2014. Complications of preterm births accounted 
for 35% of NNDs. Haas [11] reported that 
understanding the complexities of cost-effective 
interventions becomes increasingly important. A lot of 
research is needed about iatrogenic unwanted preterm 
births.  
A lot of awareness about IUD and immediate 
neonatal death, amongst population and even health 
providers is essential. For prevention of SB it is 
essential to have preconception literacy and care, 
quality pregnancy management, antepartum fetal 
surveillance. World health organization [12] has 
recently changed its antenatal guidelines with 5 
antenatal care visits between 34 to 40 weeks mainly to 
prevent IUD, SB. It is essential to have quality care as 
problem is not only numbers, it is contents and quality 
of antenatal and intranatal care. Also there are issues 
like placental bed thrombosis, true knot in umblical 
cord, cord entanglement, beyond health care. It is 
essential to take proper efforts to know the possible 
causes. Health system needs to respond.  
Preconception care offers a window of opportunity 
to introduce a positive agenda for better outcome for 
baby. In diabetics preconception counseling and 
planning to achieve better glycemic control in 
pregnancy can do a lot. When FGR is identified 
antenatally, there are fetal assessment tests such as 
non stress test, biophysical profies, and umblical artery 
doppler assessment which can be used to assess risk. 
First trimester screen, medical history, demographic 
data, mean arterial pressure, uterine artery pulsatile 
index and pregnancy associated plasma protein A can 
help in predicting FGR which is a major cause of SB. 
The most common approach, using serial 
measurement of the fundal height has very limited 
sensitivity and specificity [13]. There are numerous 
other challenges in identification of FGR. For neonatal 
safe survival, some simple interventions can be life 
saving in any setting like keeping babies warm, with 
skin to skin contact, exclusive breastfeeding, 
immunization. Mothers of small premature babies could 
play a vital role in their baby’s survival. There is 
consistent evidence that pregnancies conceived less 
than 19-24 months after a live birth are at increased 
risk o adverse outcomes [14]. Nevertheless, WHO 
recommendations endorse an interval of at least 24 
months after a live birth, and 12 months after a 
miscarriage, [15] before becoming pregnant again, but 
there are no recommendations for the optimal interval 
after a stillbirth (fetal loss after mid-pregnancy).  
 Further women do not know the differences 
between disorders/factors, which cause IUD and 
immediate NND. So, they do not tell the details. Even 
health providers do not go in depth during questioning 
about the loss, which could be intrauterine or during 
birth or immediately after birth. Etiology could be 
different. If cause is not known then track of 
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appropriate investigations is not taken which leads to a 
lot of unnecessary investigations, a lot of stress to the 
woman and family and the health providers not being 
able to prevent recurrence. So it is essential that 
women are sensitively asked about exactly what 
happened to get desired information and accordingly 
take action. It is essential to create awareness in 
community, especially women of reproductive age. 
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